Search filters

List of works by Craig Innes

A novel HIV treatment model using private practitioners in South Africa

scientific article published on March 2012

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

scientific article published on 22 May 2020

Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events

scientific article published on January 2008

Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme

scientific article

Changing predictors of mortality over time from cART start: implications for care

scientific article

Evaluation of a workplace HIV treatment programme in South Africa

scientific article published on July 2007

HIV suppression with stavudine 30 mg versus 40 mg in adults over 60 kg on antiretroviral therapy in South Africa

scientific article published on August 2009

Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program

scientific article published on December 2008

Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa

scientific article published on 01 September 2019

Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk

scientific article published on 15 March 2021

Landscapes of binding antibody and T-cell responses to pox-protein HIV vaccines in Thais and South Africans

scientific article published on 30 January 2020

Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa

scientific article

Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines

scientific article published on 24 February 2020

Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.

scientific article

Paulina is supported by:

About Paulina

Help